TNSN93081A1 - Procede de preparation de derives de la n-(phenylethyl-b-ol) amine - Google Patents

Procede de preparation de derives de la n-(phenylethyl-b-ol) amine

Info

Publication number
TNSN93081A1
TNSN93081A1 TNTNSN93081A TNSN93081A TNSN93081A1 TN SN93081 A1 TNSN93081 A1 TN SN93081A1 TN TNSN93081 A TNTNSN93081 A TN TNSN93081A TN SN93081 A TNSN93081 A TN SN93081A TN SN93081 A1 TNSN93081 A1 TN SN93081A1
Authority
TN
Tunisia
Prior art keywords
phenylethyl
preparation
amine derivatives
amine
tetrahydrofurylalkyle
Prior art date
Application number
TNTNSN93081A
Other languages
English (en)
Inventor
Auvin Serge
Braquet Pierre
Broquet Colette
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of TNSN93081A1 publication Critical patent/TNSN93081A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'INVENTION CONCERNE UN PROCEDE POUR LA PREPARATION D'UN DERIVE, SOUS FORME RACEMIQUE OU D'ENANTIOMERES, DE LA N-(TETRAHYDROFURYLALKYLE)- N-(PHENYLETHYL-B-OL) AMINE, LE RADICAL FURYL ETANT DISUBSTITUE EN POSITION 2,4- OU 2,5-, DE FORMULE GENERALE I DANS LAQUELLE R REPRESENTE DIVERS RADICAUX ET n VARIE DE 1 A 10.
TNTNSN93081A 1992-07-17 1993-07-16 Procede de preparation de derives de la n-(phenylethyl-b-ol) amine TNSN93081A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215274A GB9215274D0 (en) 1992-07-17 1992-07-17 Derivatives of(phenylethyl-beta-ol)amine

Publications (1)

Publication Number Publication Date
TNSN93081A1 true TNSN93081A1 (fr) 1994-03-17

Family

ID=10718914

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN93081A TNSN93081A1 (fr) 1992-07-17 1993-07-16 Procede de preparation de derives de la n-(phenylethyl-b-ol) amine

Country Status (32)

Country Link
US (1) US5447942A (fr)
JP (1) JP3204811B2 (fr)
AT (1) AT403693B (fr)
AU (1) AU672791B2 (fr)
BE (1) BE1006429A3 (fr)
CA (1) CA2100381C (fr)
CH (1) CH687705A5 (fr)
DE (1) DE4323976C2 (fr)
DK (1) DK84793A (fr)
DZ (1) DZ1704A1 (fr)
ES (1) ES2067417B1 (fr)
FI (1) FI933235A (fr)
FR (2) FR2693653B1 (fr)
GB (2) GB9215274D0 (fr)
GR (1) GR1001565B (fr)
HK (1) HK52596A (fr)
HU (1) HUT64757A (fr)
IE (1) IE73266B1 (fr)
IN (1) IN183086B (fr)
LU (1) LU88383A1 (fr)
MA (1) MA22937A1 (fr)
MY (1) MY109395A (fr)
NL (1) NL9301241A (fr)
NO (1) NO302946B1 (fr)
NZ (1) NZ248041A (fr)
OA (1) OA09838A (fr)
PL (1) PL173783B1 (fr)
PT (1) PT101308B (fr)
RU (1) RU2060252C1 (fr)
SE (1) SE503805C2 (fr)
TN (1) TNSN93081A1 (fr)
ZA (1) ZA934667B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025920A2 (fr) * 2004-06-19 2006-03-09 Human Biomolecular Research Institute Modulateurs de neurotransmetteurs du systeme nerveux central
WO2020148325A1 (fr) 2019-01-15 2020-07-23 Phenex-Fxr Gmbh Modulateurs de lxr neutres

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700692A (en) 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
NZ211822A (en) * 1984-04-17 1988-11-29 Glaxo Group Ltd Phenethanolamine derivatives and pharmaceutical compositions
DE3731198A1 (de) * 1987-02-07 1988-08-18 Bayer Ag 2-aminomethyltetrahydrofurane
EP0286242A3 (fr) * 1987-03-12 1989-08-09 Glaxo Group Limited Dérivés d'ethanolamine, procédés pour leur preparations et compositions pharmaceutiques les contenant
GB2230525A (en) * 1989-04-14 1990-10-24 Glaxo Group Ltd 1-(Hydroxyphenyl)-2-aminoethanol derivatives
GB2230775A (en) * 1989-04-24 1990-10-31 Glaxo Group Ltd Phenethanolamine compounds
TW209832B (fr) * 1989-10-10 1993-07-21 Glaxo Group Ltd

Also Published As

Publication number Publication date
IE73266B1 (en) 1997-05-21
ATA142793A (de) 1997-09-15
AU672791B2 (en) 1996-10-17
SE9302437D0 (sv) 1993-07-16
DK84793A (da) 1994-01-18
AU4204293A (en) 1994-01-20
AT403693B (de) 1998-04-27
DE4323976A1 (de) 1994-01-20
FR2693723A1 (fr) 1994-01-21
SE503805C2 (sv) 1996-09-09
NO302946B1 (no) 1998-05-11
CA2100381A1 (fr) 1994-01-18
GR1001565B (el) 1994-05-31
MA22937A1 (fr) 1994-04-01
GB2268742A (en) 1994-01-19
FR2693653A1 (fr) 1994-01-21
LU88383A1 (fr) 1994-04-01
HU9302057D0 (en) 1993-10-28
JP3204811B2 (ja) 2001-09-04
ZA934667B (en) 1994-01-25
RU2060252C1 (ru) 1996-05-20
GB9314718D0 (en) 1993-08-25
HUT64757A (en) 1994-02-28
FI933235A (fi) 1994-01-18
NO932383L (no) 1994-01-18
CA2100381C (fr) 2004-09-21
DE4323976C2 (de) 2003-05-28
FI933235A0 (fi) 1993-07-16
DK84793D0 (da) 1993-07-16
CH687705A5 (fr) 1997-01-31
ES2067417B1 (es) 1995-11-16
IE930472A1 (en) 1994-01-26
NO932383D0 (no) 1993-06-29
FR2693723B1 (fr) 1994-10-28
US5447942A (en) 1995-09-05
NZ248041A (en) 1994-06-27
SE9302437L (sv) 1994-01-18
ES2067417A1 (es) 1995-03-16
JPH06157492A (ja) 1994-06-03
MY109395A (en) 1997-01-31
NL9301241A (nl) 1994-02-16
PL299693A1 (en) 1994-03-21
HK52596A (en) 1996-04-03
GB9215274D0 (en) 1992-09-02
PT101308B (pt) 1999-10-29
BE1006429A3 (fr) 1994-08-23
PT101308A (pt) 1994-05-31
OA09838A (fr) 1994-08-15
PL173783B1 (pl) 1998-04-30
GB2268742B (en) 1995-11-08
IN183086B (fr) 1999-09-04
FR2693653B1 (fr) 1994-10-28
DZ1704A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
LU90160I2 (fr) Naratriptan facultativement sous la forme d'un sel pharmaceutiquement acceptable ou d'un solvate y compris le chlorhydrate de naratriptan
PT91417A (pt) Processo para a preparacao de derivados indolicos
PT784974E (pt) Preparacao de derivados de xantina numa dispersao solida
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
TNSN92022A1 (fr) Procede de preparation de nouveaux derives de l'indole
TNSN93081A1 (fr) Procede de preparation de derives de la n-(phenylethyl-b-ol) amine
ATE76399T1 (de) Enantiomere glutaramide als harntreibende verbindungen.
DE69004989D1 (de) Indolderivate.
FI102748B1 (fi) Menetelmä N-(2,6-dialkyylifenyyli)-2-(2-okso-1-pyrrolidinyyli)asetamidijohdannaisen valmistamiseksi
BE905154A (fr) Acides n-nicotinoylamines.
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
IT1264695B1 (it) N-derivati di (feniletil-beta-ol)ammina, un procedimento per la loro preparazione e composizione farmaceutiche che li contengono
FR2540515B1 (fr) Procede de preparation d'acides amines optiquement actifs par synthese enzymatique
MY103509A (en) Indole derivatives.